NCT05505279View on ClinicalTrials.gov

Ventilatory Effects of THRIVE During EBUS

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

August 8, 2024

Study Completion Date

August 8, 2024

Conditions
HypercapniaSedation ComplicationHigh Flow Nasal Cannula
Interventions
DEVICE

THRIVE (High Flow Nasal Cannula)

2 different rates of nasal flow compared to each other and a baseline of level of nasal oxygen

Trial Locations (1)

6815 AD

Rijnstate Hospital, Arnhem

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Rijnstate Hospital

OTHER